IL189459A - Use of triazole derivatives in the manufacture of a medicament for treating and prophylaxis of disorders, some such compounds and pharmaceutical compositions comprising some such compounds - Google Patents

Use of triazole derivatives in the manufacture of a medicament for treating and prophylaxis of disorders, some such compounds and pharmaceutical compositions comprising some such compounds

Info

Publication number
IL189459A
IL189459A IL189459A IL18945908A IL189459A IL 189459 A IL189459 A IL 189459A IL 189459 A IL189459 A IL 189459A IL 18945908 A IL18945908 A IL 18945908A IL 189459 A IL189459 A IL 189459A
Authority
IL
Israel
Prior art keywords
compounds
prophylaxis
medicament
disorders
treating
Prior art date
Application number
IL189459A
Other languages
Hebrew (he)
Other versions
IL189459A0 (en
Original Assignee
Centre Nat Rech Scient
Univ Montpellier Ii
Univ Montpellier I
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05017732A external-priority patent/EP1757290A1/en
Application filed by Centre Nat Rech Scient, Univ Montpellier Ii, Univ Montpellier I, Aeterna Zentaris Gmbh filed Critical Centre Nat Rech Scient
Publication of IL189459A0 publication Critical patent/IL189459A0/en
Publication of IL189459A publication Critical patent/IL189459A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL189459A 2005-08-15 2008-02-12 Use of triazole derivatives in the manufacture of a medicament for treating and prophylaxis of disorders, some such compounds and pharmaceutical compositions comprising some such compounds IL189459A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US70794105P 2005-08-15 2005-08-15
EP05017732A EP1757290A1 (en) 2005-08-16 2005-08-16 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
US78754306P 2006-03-31 2006-03-31
PCT/EP2006/007945 WO2007020013A2 (en) 2005-08-15 2006-08-11 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors

Publications (2)

Publication Number Publication Date
IL189459A0 IL189459A0 (en) 2008-12-29
IL189459A true IL189459A (en) 2015-08-31

Family

ID=41168847

Family Applications (1)

Application Number Title Priority Date Filing Date
IL189459A IL189459A (en) 2005-08-15 2008-02-12 Use of triazole derivatives in the manufacture of a medicament for treating and prophylaxis of disorders, some such compounds and pharmaceutical compositions comprising some such compounds

Country Status (4)

Country Link
HK (1) HK1121681A1 (en)
IL (1) IL189459A (en)
NO (1) NO342380B1 (en)
RU (1) RU2415134C9 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016130901A2 (en) * 2015-02-12 2016-08-18 University Of Southern California Blockers of the growth hormone receptor in disease prevention and treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518292B1 (en) * 1999-03-12 2003-02-11 Bristol-Myers Squibb Co. Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
AU779426B2 (en) * 1999-11-15 2005-01-27 Janssen Pharmaceutica N.V. Triazoles as farnesyl transferase inhibitors

Also Published As

Publication number Publication date
RU2415134C9 (en) 2011-05-27
NO342380B1 (en) 2018-05-14
IL189459A0 (en) 2008-12-29
RU2008109929A (en) 2009-09-27
RU2415134C2 (en) 2011-03-27
NO20081248L (en) 2008-05-05
HK1121681A1 (en) 2009-04-30

Similar Documents

Publication Publication Date Title
IL183108A (en) Triazole compounds, pharmaceutical compositions containing them and their use in the manufacture of medicaments for treating proliferation disorders
IL184148A (en) Substituted triazole derivatives as oxytocin antagonists, pharmaceutical compositions comprising them and their use in the preparation of medicaments for treating disorders where inhibition of oxytocin produces a beneficial effect
IL202158A (en) Oxadiazole derivatives, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments for the treatment of neurological and psychiatric disorders
IL195142A (en) Substituted arylimidazolone and triazolone, process for their preparation and pharmaceutical compositions comprising the same for the treatment or prophylaxis of diseases
IL192763A (en) Pyrimidine derivatives, compositions comprising them and use thereof for the manufacture of medicaments for the treatment of cancer
IL189578A (en) Pyridine derivatives, pharmaceutical compositions comprising them and uses thereof in the preparation of medicaments for the treatment of cns disorders
IL179714A (en) Pharmaceutical composition comprising derivatives of 2-biphenyl-4-yl-2,3-dihydro-1h-quinazolin-4-one and use thereof in the manufacture of medicaments for treating cancer and angiogenesis
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
IL206296A (en) Aminopyrazole derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments for prevention or treatment of diseases
HK1092722A1 (en) Pharmaceutical compositions and their use for manufacturing the medicament for treating atherosclerosis, dyslipidemias and related conditions
IL194678A (en) Kinase inhibitor compounds, pharmaceutical compositions comprising the same and uses thereof in the preparation of medicaments for treating cancer in a mammal
HK1166983A1 (en) Solid forms comprising compounds for the treatment of diseases or disorders, compositions thereof, and use therewith
IL193762A (en) Compounds useful in inhibiting dgat1-related disorders, pharmaceutical compositions comprising them and use thereof in preparation of medicaments
IL181304A (en) Use of dihydropteridinones for the preparation of a pharmaceutical composition for treating myelodysplastic syndrome
IL199362A (en) Pyridopyrimidine compounds, pharmaceutical compositions comprising them, the compounds for use as medicaments and use of the compounds in the manufacture of medicaments
IL186303A (en) 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position, pharmaceutical compositions comprising same and use thereof for preparation of a medicament for treating cancer
IL200212A (en) Heterocyclic carboxamide compounds, pharmaceutical compositions comprising the same and uses thereof in the manufacture of medicaments for treating or lessening the severity of a disease or condition selected from cancer and arthritis
IL231576A (en) Adamantyl-acetamide derivatives, pharmaceutical compositions comprising same and use thereof in the manufacture of medicaments
IL181524A (en) Heterocyclic compounds, pharmaceutical compositions containing them and their use in the manufacture of medicaments
IL206399A (en) Aminotriazole derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
IL184712A (en) Pyrazolo-pyrimidine derivatives, process of their manufacture, pharmaceutical compositions comprising them and use for the preparation of medicaments
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
IL202505A (en) 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumors, medicaments comprising them and use thereof
IL191310A (en) Factor xa variant which increases hemostasis, pharmaceutical composition comprising the same and use thereof in the manufacture of medicaments for treatment of hemostasis- related disorders

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed